Financial Information

Here you will find a summary of EyePoint Pharmaceuticals' latest financial information.

Latest Proxy Statement

Form	Filing date	View
DEF 14A	Apr 26, 2024	View HTML 0000950170-24-049067.pdf

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Source: LSEG

EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018- EyePoint Pharmaceuticals, Inc. All Rights Reserved.

Market Capitalization (Mil)	$591.07
Shares Outstanding (Mil)	68.10
Shares Outstanding, Average (FY) (Mil)	38.90
Float (Mil)	66.28